Additionally, Quercetin has been reported as a promising therapeutic agent for intervertebral disc degeneration, potentially through binding to the Keap1-Nrf2 complex and suppressing the NF-κB pathway (Shao et al., 2021). The gene discussed is KEAP1; the disease is Intervertebral disk degeneration.